MDClone is a healthcare data analytics company whose ADAMS platform lets organizations explore health data using synthetic data.
Founded in 2016 and headquartered in Beersheba, Israel, MDClone Ltd. provides healthcare data analytics through its ADAMS platform, a self-service environment for exploring and analyzing health data. The platform uses synthetic data to support security and compliance, with use cases such as kidney disease management and intracranial hemorrhage detection. In March 2022 the company raised USD 63.00 mn in Series C funding, with investors including Lightspeed Venture Partners, OrbiMed Advisors, Viola Group, Warburg Pincus and aMoon.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in